Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial

Trials. 2022 Feb 10;23(1):134. doi: 10.1186/s13063-022-06079-1.
No abstract available

Publication types

  • Published Erratum